Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,804	1,829	1,318	1,260	985	1,154
Market Cap Growth	-13.94%	38.81%	4.57%	27.92%	-14.60%	-25.58%
Enterprise Value	2,307	2,240	1,629	1,521	1,202	1,377
Last Close Price	751.70	761.13	547.29	522.40	408.39	476.46
PE Ratio	181.29	188.91	144.98	156.37	-	317.23
PS Ratio	7.97	8.34	6.65	6.96	9.95	4.04
PB Ratio	59.76	62.17	56.46	23.92	21.97	19.94
P/TBV Ratio	59.76	62.17	56.46	23.92	21.97	19.94
EV/Sales Ratio	10.19	10.22	8.22	8.40	12.14	4.83
EV/EBITDA Ratio	128.87	122.73	80.79	77.41	-	75.98
EV/EBIT Ratio	185.37	180.50	123.64	102.35	-	119.74
EV/FCF Ratio	-20.90	-	-	-	-	-
Debt / Equity Ratio	20.83	16.23	16.82	6.55	5.35	3.94
Debt / EBITDA Ratio	35.13	25.86	18.95	16.49	-	11.72
Asset Turnover	0.36	0.40	0.39	0.39	0.23	0.69
Inventory Turnover	0.47	0.49	0.49	0.54	0.40	0.88
Quick Ratio	0.47	0.38	0.34	0.29	0.29	0.22
Current Ratio	0.92	0.91	0.88	0.92	0.87	0.89
Return on Equity (ROE)	37.67%	36.70%	23.91%	16.53%	-25.34%	6.29%
Return on Assets (ROA)	1.22%	1.41%	1.62%	2.01%	-1.07%	1.73%
Return on Capital (ROIC)	1.41%	1.68%	2.02%	2.72%	-1.60%	2.55%
Return on Capital Employed (ROCE)	35.60%	36.30%	44.70%	24.80%	-	17.00%
Earnings Yield	0.55%	0.53%	0.69%	0.64%	-1.32%	0.32%
FCF Yield	-6.12%	-3.72%	-2.68%	-5.93%	-0.55%	-1.10%
Dividend Yield	0.13%	0.13%	0.27%	0.19%	-	0.32%
Payout Ratio	57.95%	34.91%	11.00%	18.61%	-	81.16%
Total Shareholder Return	0.13%	0.13%	0.27%	0.19%	-	0.32%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.